Constitutive and functionally relevant expression of JAM-C on platelets

Thrombosis and Haemostasis

Volumn 103, Issue 4, 2010, Pages 857-859

  Erpenbeck, Luise ^a,b   Rubant, Simone ^c   Hardt, Katja ^c   Santoso, Sentot ^d   Boehncke, Wolf Henning ^c   Schön, Michael P ^a,b   Ludwig, Ralf J ^b,e  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

JUNCTIONAL ADHESION MOLECULE C; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CELLULAR DISTRIBUTION; ENDOTHELIUM CELL; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; COLLAGEN; FLOW CYTOMETRY; HUMANS; MICROSCOPY, VIDEO; PLATELET ACTIVATION; RECEPTORS, THROMBIN; STRESS, MECHANICAL; THROMBIN;

EID: 77952034228     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-08-0572     Document Type: Letter

References (21)

1. Bazzoni G, Martinez-Estrada OM, Orsenigo F, et. al. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 2000; 275: 20520-22056 (Pubitemid 30457633)
2. Ebnet K, Schulz CU, Meyer zu Brickwedde MK, et. al. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem 2000; 275: 27979-27988.
3. Kostrewa D, Brockhaus M, D'Arcy A, et al. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J 2001; 20: 4391-4398. (Pubitemid 32772033)
4. Muller WA. Migration of leukocytes across endothelial junctions: some concepts and controversies. Microcirculation 2001; 8: 181-193.
5. Ody C, Jungblut-Ruault S, Cossali D, et al. Junctional adhesion molecule C (JAM-C) distinguishes CD27+ germinal center B lymphocytes from nongerminal center cells and constitutes a new diagnostic tool for B-cell malignancies. Leukemia 2007; 21: 1285-1293. (Pubitemid 46831818)
6. Immenschuh S, Naidu S, Chavakis T, et. al. Transcriptional induction of junctional adhesion molecule-C gene expression in activated T cells. J Leukoc Biol 2009; 85: 796-803
7. Imhof BA, Zimmerli C, Gliki G, et al. Pulmonary dysfunction and impaired granulocyte homeostasis result in poor survival of Jam-C-deficient mice. J Pathol 2007; 212: 198-208. (Pubitemid 46852098)
8. Palmer G, Busso N, Aurrand-Lions M, et al. Expression and function of junctional adhesion molecule-C in human and experimental arthritis. Arthritis Res Ther 2007; 9: R65. (Pubitemid 47249055)
9. Ludwig RJ, Zollner TM, Santoso S, et al. Junctional Adhesion Molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. J Invest Dermatol 2005; 125: 969-976.
10. Lamagna C, Hodivala-Dilke KM, Imhof BA, et. al. Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth. Cancer Res 2005; 65: 5703-5710.
11. Weber C, Fraemohs L, Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 2007; 7: 467-477. (Pubitemid 46834851)
12. Keiper T, Al-Fakhri N, Chavakis E, et al. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J 2005;1 9: 2078-2080. (Pubitemid 41759771)
13. Shagdarsuren E, Djalali-Talab Y, Aurrand-Lions M, et al. Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone mice-brief report. Arterioscler Thromb Vasc Biol 2009; 29: 1161-1163.
14. Kinashi T, Aker M, Sokolovsky-Eisenberg M, et al. LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood 2004; 103: 1033-1036. (Pubitemid 38129568)
15. Oostingh GJ, Ludwig RJ, Enders S, et al. Diminished lymphocyte adhesion and alleviation of allergic responses by small-molecule- or antibody-mediated inhibition of L-selectin functions. J Invest Dermatol 2007; 127: 90-97. (Pubitemid 46005665)
16. Oostingh GJ, Pozgajova M, Ludwig RJ, et al. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions. Haematologica 2007; 92: 502-512. (Pubitemid 350144296)
17. Langer HF, Daub K, Braun G, et al. Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol 2007; 27: 1463-1470. (Pubitemid 46809439)
18. Ludwig RJ, Schön MP, Boehncke WH. P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis. Expert Opin Ther Targets 2007; 11: 1103-1117.
19. Gelfand JM, Neimann AL, Shin DB, et. al. Risk of myocardial infarction in patients with psoriasis. J Am Med Assoc 2006; 296: 1735-1741. (Pubitemid 44547793)
20. Ludwig RJ, Herzog C, Rostock A, et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007; 156: 271-276. (Pubitemid 46095954)
21. Rubant SA, Ludwig RJ, Diehl S, et al. Dimethylfumarate Reduces Leukocyte Rolling in vivo through modulation of adhesion molecule expression. J Invest Dermatol 2007; 128: 326-331.